Literature DB >> 25207251

Successful repair of critical tricuspid regurgitation secondary to a ruptured papillary muscle in a neonate.

Jooncheol Min1, Eung Re Kim1, Chan Kyu Yang1, Woong-Han Kim1, Woo Sung Jang1, Sungkyu Cho1.   

Abstract

Severe tricuspid regurgitation resulting from a flail leaflet is a rare cause of neonatal cyanosis. We report a neonate with profound cyanosis and severe tricuspid regurgitation caused by a rupture of the papillary muscle supporting the anterior leaflet, without other structural heart defects. Ductal patency could not be established. The repair of the tricuspid valve was performed after initial stabilization by using extracorporeal membrane oxygenation.

Entities:  

Keywords:  Extracorporeal membrane oxygenation; Neonate; Papillary muscles; Tricuspid valve insufficiency; Tricuspid valve surgery

Year:  2014        PMID: 25207251      PMCID: PMC4157505          DOI: 10.5090/kjtcs.2014.47.4.398

Source DB:  PubMed          Journal:  Korean J Thorac Cardiovasc Surg        ISSN: 2233-601X


CASE REPORT

A 3,240-g male neonate born at the 39th week of gestation was transferred to Seoul National University Hospital due to severe cyanosis and cardiac arrest. Pregnancy and delivery had been uneventful, and the prenatal ultrasound had been normal. There was no history of perinatal distress. Soon after birth, the baby developed severe cyanosis. Although ventilator support was provided, he remained profoundly hypoxemic, and cardiac arrest occurred. After restoration of spontaneous circulation with cardiopulmonary resuscitation (CPR), he was transferred to Seoul National University Hospital 3 hours after birth. An infantogram taken immediately after admission revealed a pneumothorax on the right side (Fig. 1A); thus, we performed a closed thoracostomy. Although the lung was fully expanded after the closed thoracostomy (Fig. 1B), the observed oxygen saturation level did not improve. Transthoracic echocardiogram (TTE) showed severe tricuspid regurgitation (TR), with a flail anterior leaflet having a thickened, echogenic tip (Fig. 2A). The pulmonary valve had a normal appearance, but the antegrade pulmonary flow was nearly absent, consistent with functional pulmonary atresia. A right-to-left shunt was detected through the patent foramen ovale, and patent ductus arteriosus was not present. The right atrium and ventricle were not markedly dilated, favoring the acute occurrence of secondary TR due to a papillary muscle rupture.
Fig. 1

(A) Initial infantogram showing a right pneumothorax. (B) Infantogram after closed thoracostomy.

Fig. 2

(A) Preoperative transthoracic echocardiogram showing a flail anterior leaflet of the tricuspid valve with a thickened echogenic tip prolapsing into the right atrium (arrow). (B) Postoperative transthoracic echocardiogram showing the artificial cord supporting the leaflet and the restoration of adequate coaptation. RA, right atrium; RV, right ventricle; LV, left ventricle.

Despite maximum conventional ventilator support, the neonate continued to be severely hypoxemic, with an oxygen saturation of less than 60%. Continuous inhalation of nitric oxide, aimed at lowering the pulmonary vascular resistance was attempted, but this produced a minimal increase in oxygenation. Other adjunctive measures, including infusion of sodium bicarbonate, inotropic agents, and prostaglandin E5, all failed to improve either oxygenation or the state of low cardiac output. The heart failure became progressive, and cardiac arrest occurred repeatedly, necessitating CPR. The patient was placed on venoarterial extracorporeal membrane oxygenation (ECMO) at 36 hours of life, and tricuspid repair was undertaken. Ascending aortic and bicaval cannulation was implanted, and mild hypothermic cardiopulmonary bypass was maintained. The papillary muscle of the anterior tricuspid valve (TV) leaflet was ruptured, showing organized and ischemic change (Fig. 3A). We reimplanted the ruptured papillary muscle head into the healthy endocardium (7-0 polytetrafluoroethylene [PTFE] pledget-supported suture) and created artificial chordae from 7/0 PTFE in the case of papillary muscle re-rupture (Fig. 3B). The ligamentum arteriosum was divided, and the patent foramen ovale was preserved. The patient was weaned easily from bypass on low-dose inotropics. Ventilation with nitric oxide was necessary for the next few days, which was followed by extubation on the 11th postoperative day. TTE on the 17th postoperative day showed negligible TR and good systolic function of both ventricles (Fig. 2B). The patient was discharged on the 20th postoperative day. After 6 months of postoperative follow-up, the patient remained very well and his TTE showed normal cardiac function with trivial TR.
Fig. 3

(A) Intraoperative finding of a ruptured papillary muscle of the anterior leaflet of the tricuspid valve (arrow). (B) Schematic representation of the papillary muscle reimplantation and the creation of the artificial chordae (a, native chordae; b, pledget-supported polytetrafluoroethylene suture at the ruptured papillary muscle; c, artificial chordae).

DISCUSSION

Papillary muscle rupture in a neonate is a rare event that leads to severe mitral or tricuspid insufficiency and is associated with high perinatal mortality. There are few reports in the English literature regarding cases of newborns with critical atrioventricular valve insufficiency secondary to ruptured papillary muscle or chordae tendinae [1]. Further, in the Korean literature, one case was reported in 1997 [2]. Hypoxia in the newborn is a possible cause of papillary muscle dysfunction, pulmonary hypertension, and tricuspid insufficiency. Myocardial ischemia, which can result from antepartum or peripartum asphyxia, congenital heart disease, viral infections, Rhesus isoimmunization, thromboembolism, or other more obscure causes, can induce a papillary muscle rupture [1]. Furthermore, permanent antenatal ductal closure is an interesting cause of the papillary muscle rupture of the tricuspid valve. If ductal closure occurs suddenly, a tremendous increase in the right ventricular afterload would result during severe fetal stress, and the combined hemodynamic and metabolic insult might provoke an ischemic rupture of the tricuspid papillary muscle [3]. Gerry et al. [4] reported two cases of a ruptured papillary muscle of the TV as a complication of CPR. However, tricuspid insufficiency is thought to be a rare complication of blunt, non-penetrating chest trauma. Parmley et al. [5] found 24 cases of papillary muscle ruptures in an autopsy study of 546 cases of trauma, but there was only one instance of an isolated rupture of the tricuspid papillary muscle. Almost all of these cases had coexisting myocardial lesions such as myocardial ruptures. In our case, the etiology of the papillary muscle rupture is unclear because TR was not diagnosed before CPR. However, soon after birth and prior to CPR, the patient had already developed severe cyanosis, which might have been related to severe TR with functional pulmonary atresia. This supports the echocardiographic and intraoperative findings that suggest that the rupture of the papillary muscle was induced by myocardial ischemia. TR secondary to a papillary muscle rupture may be sufficiently severe to preclude an antegrade pulmonary flow, with a resultant massive right-to-left atrial shunt. Medical treatment, which is aimed at reducing the high pulmonary vascular resistance, allows for an increase in the antegrade flow from the right ventricle and may also improve the systemic perfusion. However, the inability to open the ductus limits the therapeutic options, with the exception of ECMO [6]. In our case, severe TR without ductal patency did not provide appropriate vital signs; thus, the repair of TV was performed after initial stabilization by using ECMO. A number of similar cases have been reported for the use of ECMO as a bridge to TV repair [7]. Long-term follow-up studies on PTFE artificial chordae in TV repair in children are lacking. However, promising results have been achieved with the use of the artificial chordae of the mitral valve. Freedom from reoperation with chordal placement in the mitral valve position was 94.7% at 5 years and 89.5% at 8 years [8]. Considering that PTFE sutures lack the possibility of growth, further studies on the TV position in neonates is warranted.
  7 in total

1.  Nonpenetrating traumatic injury of the heart.

Authors:  L F PARMLEY; W C MANION; T W MATTINGLY
Journal:  Circulation       Date:  1958-09       Impact factor: 29.690

2.  Successful management of severe tricuspid regurgitation associated with hydrops fetalis in a case of dysplastic tricuspid valve.

Authors:  Y Misu; S Hiraishi; K Oguchi; K Amano
Journal:  Pediatr Cardiol       Date:  1999 Nov-Dec       Impact factor: 1.655

3.  Ruptured tricuspid valve papillary muscle: a treatable cause of neonatal cyanosis.

Authors:  Ritu Sachdeva; Richard T Fiser; William R Morrow; Joseph R Cava; Nancy S Ghanayem; Robert D B Jaquiss
Journal:  Ann Thorac Surg       Date:  2007-02       Impact factor: 4.330

4.  Rupture of the papillary muscle of the tricuspid valve. A complication of cardiopulmonary resuscitation and a rare cause of tricuspid insufficiency.

Authors:  J L Gerry; B H Bulkley; G M Hutchins
Journal:  Am J Cardiol       Date:  1977-11       Impact factor: 2.778

5.  Neonatal mitral and tricuspid valve repair for in utero papillary muscle rupture.

Authors:  Petros V Anagnostopoulos; Nelson Alphonso; Lars Nölke; Lisa K Hornberger; Gary W Raff; Anthony Azakie; Tom R Karl
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

6.  Midterm results of mitral valve repair with artificial chordae in children.

Authors:  Kazu Minami; Hideaki Kado; Sadahiro Sai; Hideki Tatewaki; Yuichi Shiokawa; Atsuhiro Nakashima; Koji Fukae; Hitoshi Hirose
Journal:  J Thorac Cardiovasc Surg       Date:  2005-02       Impact factor: 5.209

7.  Papillary muscle necrosis in a neonatal autopsy population: incidence and associated clinical manifestations.

Authors:  E Setzer; R Ermocilla; I Tonkin; E John; M Sansa; G Cassady
Journal:  J Pediatr       Date:  1980-02       Impact factor: 4.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.